← Alignment Healthcare, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $757.0m |
$959.2m
+26.72%
|
$1.2b
+21.74%
|
$1.4b
+22.81%
|
$1.8b
+27.16%
|
$2.7b
+48.25%
|
$3.9b
+46.06%
|
|
| Selling, General and Administrative Expense | $110.1m | $156.4m | $291.0m | $295.6m | $307.4m | $371.4m | $443.4m | |
| Amortization of Intangible Assets | — | $327k | $362k | $386k | $226k | $702k | $634k | |
| Operating Expenses | $786.4m | $964.5m | $1.3b | $1.6b | $2.0b | $2.8b | $3.9b | |
| Operating Income (Loss) | ($29.5m) |
($5.3m)
+82.15%
|
($178.1m)
-3283.47%
|
($128.6m)
+27.76%
|
($127.8m)
+0.64%
|
($101.6m)
+20.55%
|
$14.8m
+114.53%
|
|
| Interest Expense | $14.9m | $16.9m | $17.4m | $18.3m | $21.2m | $23.5m | $15.8m | |
| Other Nonoperating Income (Expense) | — | ($17.7m) | ($17.2m) | ($20.7m) | ($20.4m) | $72k | $89k | |
| Other Income | $3.0m | $3.8m | $688k | $2.6m | $22.7m | $31.6m | $37.0m | |
| Nonoperating Income (Expense) | — | — | — | — | — | ($26.5m) | ($15.7m) | |
| Other income, net | $15.2m | $17.7m | $17.2m | $20.7m | $20.4m | ($72k) | ($89k) | |
| Total other expenses | — | — | — | $20.7m | $20.4m | $26.5m | $15.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($44.7m) | ($22.9m) | ($195.3m) | ($149.3m) | ($148.2m) | ($128.1m) | ($958k) | |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $339k | ($22k) | $21k | $20k | |
| Net loss | — | ($22.9m) | ($195.3m) | ($149.6m) | ($148.2m) | ($128.1m) | ($978k) | |
| Net loss attributable to Alignment Healthcare, Inc. | ($44.7m) | ($22.9m) | ($195.3m) | ($149.5m) | ($148.0m) | ($128.0m) | ($724k) | |
| Net Income (Loss) Attributable to Parent | ($44.7m) |
($22.9m)
+48.75%
|
($195.3m)
-751.81%
|
($149.5m)
+23.42%
|
($148.0m)
+1.02%
|
($128.0m)
+13.50%
|
($724k)
+99.43%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | $0 | ($92k) | ($156k) | ($36k) | ($254k) | |
| Less: Net loss attributable to noncontrolling interest | — | $0 | $0 | $92k | $156k | $36k | ($254k) | |
| Earnings Per Share, Basic | ($0.33) | ($0.15) | ($1.14) | ($0.83) | ($0.79) | ($0.67) | $0.00 | |
| Earnings Per Share, Diluted | ($0.33) | ($0.15) | ($1.14) | ($0.83) | ($0.79) | ($0.67) | $0.00 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 188.4m | 190.8m | 198.0m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 0 | 12.6m | 19.3m | 188.4m | 190.8m | 198.0m | |
| Total weighted-average common shares outstanding - basic (in shares) | — | — | 172.0m | 181.2m | 186.2m | 190.8m | 198.0m | |
| Total weighted-average common shares outstanding - diluted (in shares) | — | — | 172.0m | 181.2m | 186.2m | 190.8m | 198.0m | |
| Additional Financial Items | ||||||||
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | — | $261.6m | $319.2m | $385.5m | $477.8m | $823.6m | $1.1b | |
| Earned premiums | $754.0m | $955.4m | $1.2b | $1.4b | $1.8b | $2.7b | $3.9b | |
| Medical expenses | $661.4m | $793.0m | $1.0b | $1.2b | $1.6b | $2.4b | $3.5b | |
| Depreciation and amortization | $14.9m | $15.1m | $15.8m | $17.3m | $21.4m | $26.9m | $30.4m | |
| Income (loss) from operations | ($29.5m) |
($5.3m)
+82.15%
|
($178.1m)
-3283.47%
|
($128.6m)
+27.76%
|
($127.8m)
+0.64%
|
($101.6m)
+20.55%
|
$14.8m
+114.53%
|
|
| Loss on extinguishment of debt | — | $0 | $0 | $2.2m | $0 | $3.0m | $0 | |
| Total | $0 | $0 | $0 | $339k | ($22k) | $21k | $20k | |
| Premiums Earned, Net | $754.0m | $955.4m | $1.2b | $1.4b | $1.8b | $2.7b | $3.9b | |
| Total expenses | $786.4m | $964.5m | $1.3b | $1.6b | $2.0b | $2.8b | $3.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.